REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $895,027 | -62.0% | 78,032 | -16.3% | 0.00% | -57.1% |
| Q2 2023 | $2,358,335 | +0.0% | 93,178 | +27.3% | 0.01% | 0.0% |
| Q1 2023 | $2,358,287 | +57.1% | 73,216 | -10.0% | 0.01% | +40.0% |
| Q4 2022 | $1,501,056 | -22.3% | 81,314 | +13.7% | 0.01% | -16.7% |
| Q3 2022 | $1,932,000 | +91.7% | 71,543 | -1.9% | 0.01% | +100.0% |
| Q2 2022 | $1,008,000 | -41.8% | 72,951 | -17.8% | 0.00% | -25.0% |
| Q1 2022 | $1,732,000 | +19.5% | 88,800 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $1,449,000 | -41.4% | 88,800 | 0.0% | 0.00% | -40.0% |
| Q3 2021 | $2,474,000 | -6.0% | 88,800 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $2,632,000 | +6.0% | 88,800 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $2,482,000 | -13.0% | 88,800 | -11.8% | 0.01% | -28.6% |
| Q4 2020 | $2,854,000 | +9.3% | 100,700 | -3.0% | 0.01% | 0.0% |
| Q3 2020 | $2,610,000 | +14.1% | 103,800 | +10.8% | 0.01% | +16.7% |
| Q2 2020 | $2,288,000 | -42.5% | 93,700 | -65.2% | 0.01% | -53.8% |
| Q1 2020 | $3,982,000 | -1.1% | 269,045 | +8.5% | 0.01% | +30.0% |
| Q4 2019 | $4,026,000 | +126.1% | 248,045 | +81.0% | 0.01% | +100.0% |
| Q3 2019 | $1,781,000 | +8.7% | 137,029 | +8.5% | 0.01% | 0.0% |
| Q2 2019 | $1,638,000 | +45.7% | 126,329 | +77.2% | 0.01% | +66.7% |
| Q1 2019 | $1,124,000 | -8.8% | 71,300 | +16.5% | 0.00% | -25.0% |
| Q4 2018 | $1,232,000 | -18.5% | 61,200 | +0.7% | 0.00% | 0.0% |
| Q3 2018 | $1,511,000 | +64.8% | 60,800 | +82.0% | 0.00% | +33.3% |
| Q2 2018 | $917,000 | +65.5% | 33,400 | +85.6% | 0.00% | +50.0% |
| Q1 2018 | $554,000 | -13.8% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $643,000 | +29.6% | 18,000 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $496,000 | +4.4% | 18,000 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $475,000 | – | 18,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |